IMUX - IMMUNIC, INC.
10.75
0.770 7.163%
Share volume: 375,270
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$9.98
0.77
0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-08-2024 | 11-07-2024 | 05-15-2025 | 08-07-2025 | 11-13-2025 | 02-26-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | |||
| Operating expenses | 23.881 M | 22.814 M | 25.726 M | 26.825 M | 27.083 M | 25.993 M | 23.327 M | |
| Selling general and admin | 5.145 M | 4.491 M | 4.356 M | 5.292 M | 5.714 M | 5.981 M | 4.258 M | |
| Research and development | 18.736 M | 18.323 M | 21.370 M | 21.533 M | 21.369 M | 20.012 M | 19.069 M | |
| Total expenses | 23.881 M | 22.814 M | 25.726 M | 26.825 M | 27.083 M | 25.993 M | 23.327 M | |
| -4.47% | 12.76% | 4.27% | 0.96% | -4.02% | -10.26% | |||
| Operating income | -23.881 M | -22.814 M | -25.726 M | -26.825 M | -27.083 M | -25.993 M | -23.327 M | |
| Ebit | -30.771 M | -22.378 M | -25.144 M | -25.656 M | -27.061 M | -25.998 M | -19.497 M | |
| Pretax income | -29.584 M | -21.380 M | -24.368 M | -25.473 M | -26.820 M | -25.579 M | -19.300 M | |
| -27.73% | 13.98% | 4.53% | 5.29% | -4.63% | -24.55% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -29.584 M | -21.380 M | -24.368 M | -25.473 M | -26.820 M | -25.579 M | -19.300 M | |
| 27.73% | -13.98% | -4.53% | -5.29% | 4.63% | 24.55% |